CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Clinical trial NCT04136171 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04136171
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-13
- Primary completion
- 2026-04-01
- Enrollment
- 1438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.